research compound is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-06-19. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Derived from published structure. |
| Molecular weight | 437.94 g/mol | Calculated value. |
| Appearance | White to off-white solid | Typical for purified research samples. |
| Solubility | DMSO, ethanol; low in water | Class: poorly water-soluble. |
| Typical storage | -20 °C, desiccated, protected from light | Limits degradation. |
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
=== PPAR-alpha agonists === An endogenous compound, 7(S)-Hydroxydocosahexaenoic Acid (7(S)-HDHA), which is a docosanoid derivative of the omega-3 fatty acid DHA was isolated as an endogenous high affinity ligand for PPAR-alpha in the rat and mouse brain. The 7(S) enantiomer bound with micromolar affity to PPAR alpha with 10 fold higher affinity compared to the (R) enantiomer and could trigger dendritic activation. PPARα (alpha) is the main target of fibrate drugs, a class of amphipathic carboxylic acids (clofibrate, gemfibrozil, ciprofibrate, bezafibrate, pemafibrate and fenofibrate). They were originally indicated for dyslipidemia of cholesterol and more recently for disorders characterized by high triglycerides.
== Phone intercepts == In September 2008, Georgia presented to the public recordings of intercepted phone calls made on 7 August by Ossetian border guards on a Georgian cellular network, which were then independently translated from the original Ossetian language by The New York Times. The recordings, allegedly proving that entry of Georgian troops into Tskhinvali was preceded by movement of part of a Russian armoured regiment into South Ossetia nearly a day earlier, were reviewed and assessed as valid by senior American government and military officials. According to a call recorded at 3:52 am on 7 August, a South Ossetian servicemen at the tunnel with the surname Gassiev was asked by a supervisor at the headquarters if the armor had arrived, to which he replied: "The armor and people." The guard also said that the people had gone through, while "they had already arrived" 20 minutes earlier. Gassiev told the supervisor in the first call at 3:41 am that an inspection of military vehicles inside the tunnel had been requested by the Russian colonel, but Gassiev did not know the exact identity of the colonel. Gassiev reported the exit of armored vehicles from the tunnel to the supervisor at 3:52 am. Authenticity of the calls was not questioned by Russia. Colonel Andrei Kazachenko who was mentioned in the recording, belonged to the 135th Motorized Rifle Regiment, according to Russian media reports after the war.
Myiasis is prevalent in livestock, and especially in domestic sheep. Myiasis in sheep is often caused by blowflies (Lucilia sericata and L. cuprina in particular) and is commonly referred to as blowfly strike. Blowfly strike, and other flystrike, occurs worldwide but is most common in regions where hot and wet conditions are sustained, such as Sub-Saharan Africa, Southeast Asia, Latin America, Australia, and New Zealand. As of 2021, blowfly strike accounts for over A$280 million a year in losses for the Australian sheep industry. As mitigation, Australian sheep farmers may engage in mulesing, a procedure designed to remove strips of wool-producing skin that are the most common targets for flies. Farmers may also dock lambs' tails to reduce the likelihood of infestation. However, both mulesing and tail-docking have received criticism from animal welfare groups, who say the mitigative procedures are excessive and can have other negative effects. In addition to blowfly strike in sheep, myiasis from screwworm flies (Cochliomyia hominivorax in particular) regularly cause upwards of US$100 million in annual damages to domestic cows and goats. Screwworm-related myiasis is primarily mitigated through the sterile insect technique.
Sources: en.wikipedia.org
== Metabolism == The bacteria rely on the enzyme glycerol-3-phosphate dehydrogenase (GPDH). GPDH is an alternative when managing electrons that are produced during metabolism. In the absence of the electron transport chain, T. pallidum uses GPDH to recycle the NAD+ by oxidizing glycerol-3-phosphate to dihydroxyacetone phosphate and make NAD+ to keep glycolysis and other redox-dependent energy reactions. By doing this, it helps balance the ATP yield without weighing down the protein's limited supply for essential tasks. T. pallidum uses an enzyme called pyrophosphate-dependent phosphofructokinase rather than ATP as a way to save energy and optimize its limited resources. T. pallidum manages without a complete tricarboxylic acid cycle and oxidative phosphorylation by using different efficient strategies including redox balancing and substrate-level to survive the nutrient-limited host environment. T. pallidum lacks enzyme orthologs for superoxide dismutase, however it does possess a superoxide reductase, maintaining the ability to reduce reactive oxygen species. In addition, T. pallidum encodes an alkyl hydroperoxide reductase C, which allows for the reduction of hydrogen peroxide to water and alcohols. This enzyme relies on TP0919, a protein present in the cytoplasm of T. pallidum. T.pallidum primarily relies on glucose as its primary carbon source through glycolysis, but one study has proposed the bacterium uses an acetogenic-energy conservation pathway as a way to catabolize D-lactate as an alternative carbon source.
=== Ultrasonication-assisted spray ionization === Ultrasonication-assisted spray ionization (UASI) is similar to the above techniques but uses an ultrasonic transducer to achieve atomization of the material and generate ions.
Commission A2: Liquefaction and Separation of Gases The work of "Commission A2: Liquefaction and Separation of Gases" reflects worldwide activities in the domain of separation of gases and liquefaction. Apart from the personal involvement of Commission members in various projects, the commission is present at conferences, workshops and seminars: LNG International Exhibition and Conference, GASTECH, Cryogenics, Cryogen Expos, European Cryogenic Course and others. The commission is close to academia, industry and end users of separated and liquefied gases. Commission members work closely with Commission A1 Cryophysics, Cryoengineering and Commission C1 Cryobiology, Cryomedicine and Health Products.
==== Post-invasion ==== In May 2003, CJSOTF-AP (Combined Joint Special Operations Task Force-Arabian Peninsula) was established to replace Task Forces Dagger, Viking and the Naval Special Operations Task Group that had commanded the SOF in the invasion. Since 2003, CJSOTF-AP was based around the 5th SFG and 10th SFG which deployed for 7-month rotations, much of CJSOTF-AP was focused on the core special forces skill set of training and advising local Iraqi forces, these units included the ICTF (Iraqi Counterrorism Force) and the ISOF. When foreign fighters and al-Qaeda terrorists began to filter into the country from Syria and Iran, the Iraqi police was fragmented and poorly supported were to be the frontline against the insurgency, police training was carried out by contractors whilst ODAs were paired with local Iraqi SWAT units to teach them tactical skills. Other Iraqi SOF were established with the assistance of the Green Berets including a SOCOM-style command. The 1st ISOF Brigade would eventually be formed to command the ICTF, 36th Commando Battalion, Reece Battalion, Iraqi Special Warfare School and a support battalion. Similarly, an Iraqi Police special operations command and the Emergency Response Brigade was raised from local Iraqi police SWAT elements, consisting of six SWAT battalions.
Sources: en.wikipedia.org
On May 17, 2015, a gunfight among rival biker gangs broke out at a Waco, Texas, Twin Peaks restaurant. Nine people were killed and eighteen others were taken to the hospital. A police spokesman expressed anger at the management of the local Twin Peaks, which he said had been less than helpful in dealing with gangs in the past. The next day, the Texas Alcoholic Beverage Commission announced a seven-day suspension of the location's liquor license. Hours later, corporate headquarters announced that it was revoking the location's franchise agreement, saying the location's owner had disregarded warnings from both police and corporate officials in the run-up to the shootout. Later that day, corporate headquarters announced the Waco location would not reopen. The same franchisee also owned a Twin Peaks in Harker Heights, near Fort Hood, but it closed at the end of September 2015. On April 2, 2019, all of the remaining criminal cases were dismissed.
The American Institute for Cancer Research (AICR) and World Cancer Research Fund International (WCRF) have stated that there is strong evidence that consuming salted foods including salt-preserved fish and salt-preserved foods in general increases risk of stomach cancer and that the high salt content of processed meat may result in damage to the stomach mucosal lining. The American Cancer Society have stated that "stomach cancer risk is increased in people whose diets include large amounts of foods preserved by salting, such as salted fish and meat and pickled vegetables." Additionally, an excessive intake of salt has a dose-response relationship with elevated blood pressure, increasing the risk of several cardiovascular diseases.
==== Autoimmune hypoglycemia ==== Antibodies can be formed against insulin, leading to autoimmune hypoglycemia. Antibodies are immune proteins produced by the body, that normally attack bacteria and viruses, but sometimes can attack normal human cells, leading to an autoimmune disorder. In autoimmune hypoglycemia, there are two possible mechanisms. In one instance, antibodies bind to insulin following its release associated with a meal, resulting in insulin being non-functional. At a later time, the antibodies fall off insulin, causing insulin to be functional again leading late hypoglycemia after a meal, called late postprandial hypoglycemia. Another mechanism causing hypoglycemia is due to antibodies formed against insulin receptors, called insulin receptor antibodies. The antibodies attach to insulin receptors and prevent insulin breakdown, or degradation, leading to inappropriately high insulin levels and low glucose levels.
=== Judges' Costumes === Episode 1: Carla Hall as creepy clown, Zac Young as Death tarot card, Stephanie Boswell as head inside a crystal ball (inspired by The Haunted Mansion's Madame Leota) Episode 2: Carla Hall as a donut shop vendor (inspired by "cousin Jesse"), Zac Young as a carousel rider, Stephanie Boswell as cotton candy Episode 3: Carla Hall as an alien (inspired by the 1996 film Mars Attacks!), Zac Young as a contortionist, Stephanie Boswell as Queen of Outer Space Episode 4: Carla Hall as a burnt fire swallowing performer, Zac Young as a magician, Stephanie Boswell as the magician's assistant who was sawed in half Episode 5: Carla Hall as Medusa, Zac Young as deformed lollipop boy, Stephanie Boswell as Harry Houdini Episode 6: Carla Hall as knife swallowing performer, Zac Young as Scare Bear, Stephanie Boswell as the Incredible Melting Woman Episode 7: Carla Hall as "Blockhead" performer, Zac Young as a circus strongman, Stephanie Boswell as a tattooed lady Episode 8: Carla Hall as conjoined twin, Zac Young as a raccoon performer, Stephanie Boswell as a lion tamer in training
Little Caesars sold its first franchise in 1962 and, by 1987, had restaurants in all 50 states. Throughout the 1990s and early 2000s, Little Caesars were commonly found in Kmart stores, more specifically in Big Kmarts and Super Kmart. Little Caesars pizza was also included in many older, remodeled Kmart locations. The first Kmarts with Little Caesars were built in Garden City, Michigan. After Kmart's bankruptcy issues, many Kmarts replaced the Little Caesars restaurants with their own branded "K-Cafe". However, as of 2021, two Little Caesars/Kmart locations remain– in Guam and USVI. Between 2008 and 2015, Little Caesars was the fastest-growing pizza chain in the United States. As of 2017, the company had 5,463 locations including U.S. and international units. The estimated total investment necessary to begin the operation of a Little Caesars Franchise ranges from $378,700 to $1,695,500.
Sources: en.wikipedia.org
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.
No. SR9009 targets the nuclear receptors REV-ERBα and REV-ERBβ, not the androgen receptor. This mechanism differs from selective androgen receptor modulators and from exercise mimetics that act on PPARδ.
Published evidence is mainly preclinical, using cell cultures and animal models. Controlled human trials are not well documented in the public literature. Claims about human performance or health effects therefore remain unsupported by robust clinical data.
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.